First Investment: 2020
Many diseases have been considered untreatable because there are no known molecules that can interrupt the given underlying biomolecular pathways. Totus uses high-throughput cell-based assays and large-scale machine learning to screen the activity of billions of compounds across the entire human genome, yielding new covalent drugs that can irreversibly bind to disease-causing proteins and silence them.
News & Insights
DCVC Announcements
In The Media
Explore Companies
Newleos Therapeutics
Transforming the treatment of anxiety and other neuropsychiatric disorders
Grove Biopharma
Putting protein-like drugs inside cells to fight cancer and neurodegeneration
Syntax Bio
Programming stem cells to differentiate into desired cell types, faster
Fable Therapeutics
Using state-of-the-art machine learning models to create custom-build protein drugs